News Releases Year: All News20182017201620152014201320122011 Items per page All News2550 June 19, 2018 Summary ToggleAllena Pharmaceuticals Completes Animal Proof-of-Concept Study for ALLN-346, Lead Product Candidate for Hyperuricemia in the Setting of Advanced Chronic Kidney Disease Read more June 11, 2018 Summary ToggleAllena Pharmaceuticals Appoints Andrew A. F. Hack, M.D., Ph.D., to its Board of Directors Read more May 30, 2018 Summary ToggleAllena Pharmaceuticals to Present at Jefferies 2018 Healthcare Conference Read more May 8, 2018 Summary ToggleAllena Pharmaceuticals Reports First Quarter 2018 Financial Results and Provides Business Update Read more March 27, 2018 Summary ToggleAllena Pharmaceuticals Reports Fourth Quarter and Full Year 2017 Financial Results and Provides Business Update Read more March 7, 2018 Summary ToggleAllena Pharmaceuticals to Present at Cowen and Company 38th Annual Health Care Conference Read more March 6, 2018 Summary ToggleAllena Pharmaceuticals Initiates First Phase 3 Trial for ALLN-177 in Patients with Enteric Hyperoxaluria Read more December 14, 2017 Summary ToggleAllena Pharmaceuticals Reports Third Quarter 2017 Financial Results and Provides Business Update Read more November 1, 2017 Summary ToggleAllena Pharmaceuticals, Inc. Announces Pricing of Initial Public Offering Read more July 27, 2017 Summary ToggleEuropean Commission Grants Orphan Drug Designation to Allena Pharmaceuticals’ Investigational Therapy for the Treatment of Primary Hyperoxaluria Read more Pagination Current page 1 Page 2 Page 3 Page 4 Next page Next Last page Last
